Am J Psychiatry 159:728-737, May 2002
© 2002 American Psychiatric Association
The Functional Neuroanatomy of the Placebo Effect
Helen S. Mayberg, M.D., F.R.C.P.C.,
J. Arturo Silva, M.D.,
Steven K. Brannan, M.D.,
Janet L. Tekell, M.D.,
Roderick K. Mahurin, Ph.D.,
Scott McGinnis, B.S., and
Paul A. Jerabek, Ph.D.
OBJECTIVE: Administration of placebo can result in a clinical response indistinguishable from that seen with active antidepressant treatment. Functional brain correlates of this phenomenon have not been fully characterized. METHOD: Changes in brain glucose metabolism were measured by using positron emission tomography in hospitalized men with unipolar depression who were administered placebo as part of an inpatient imaging study of fluoxetine. Common and unique response effects to administration of placebo or fluoxetine were assessed after a 6-week, double-blind trial. RESULTS: Placebo response was associated with regional metabolic increases involving the prefrontal, anterior cingulate, premotor, parietal, posterior insula, and posterior cingulate and metabolic decreases involving the subgenual cingulate, parahippocampus, and thalamus. Regions of change overlapped those seen in responders administered active fluoxetine. Fluoxetine response, however, was associated with additional subcortical and limbic changes in the brainstem, striatum, anterior insula, and hippocampus, sources of efferent input to the response-specific regions identified with both agents. CONCLUSIONS: The common pattern of cortical glucose metabolism increases and limbic-paralimbic metabolism decreases in placebo and fluoxetine responders suggests that facilitation of these changes may be necessary for depression remission, regardless of treatment modality. Clinical improvement in the group receiving placebo as part of an inpatient study is consistent with the well-recognized effect that altering the therapeutic environment may significantly contribute to reducing clinical symptoms. The additional subcortical and limbic metabolism decreases seen uniquely in fluoxetine responders may convey additional advantage in maintaining long-term clinical response and in relapse prevention.
This article has been cited by other articles:
|
|
|
|
 
C. B. Nemeroff, J. D. Bremner, E. B. Foa, H. S. Mayberg, C. S. North, and M. B. Stein
Posttraumatic Stress Disorder: A State-of-the-Science Review
Focus,
April 1, 2009;
7(2):
254 - 273.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Lane, S. R. Waldstein, H. D. Critchley, S. W. G. Derbyshire, D. A. Drossman, T. D. Wager, N. Schneiderman, M. A. Chesney, J. R. Jennings, W. R. Lovallo, et al.
The Rebirth of Neuroscience in Psychosomatic Medicine, Part II: Clinical Applications and Implications for Research
Psychosom Med,
February 1, 2009;
71(2):
135 - 151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Furmark, L. Appel, S. Henningsson, F. Ahs, V. Faria, C. Linnman, A. Pissiota, O. Frans, M. Bani, P. Bettica, et al.
A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety
J. Neurosci.,
December 3, 2008;
28(49):
13066 - 13074.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Oken
Placebo effects: clinical aspects and neurobiology
Brain,
November 1, 2008;
131(11):
2812 - 2823.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Diederich and C. G. Goetz
The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies
Neurology,
August 26, 2008;
71(9):
677 - 684.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Kotzalidis, I. Pacchiarotti, G. Manfredi, V. Savoja, C. Torrent, L. Mazzarini, C. Tatarelli, B. Amann, S. Di Marzo, J. Sanchez-Moreno, et al.
Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?
J Psychopharmacol,
August 1, 2008;
22(6):
590 - 597.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Nutt and A. Malizia
Why does the world have such a `down' on antidepressants?
J Psychopharmacol,
May 1, 2008;
22(3):
223 - 226.
[PDF]
|
|
|
|
|
|
|
D. J. Scott, C. S. Stohler, C. M. Egnatuk, H. Wang, R. A. Koeppe, and J.-K. Zubieta
Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses
Arch Gen Psychiatry,
February 1, 2008;
65(2):
220 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Gerber and B. S. Peterson
Measuring Transference Phenomena With fMri
J Am Psychoanal Assoc,
December 1, 2006;
54(4):
1319 - 1325.
[PDF]
|
|
|
|
|
|
|
A. M. Hunter, A. F. Leuchter, M. L. Morgan, and I. A. Cook
Changes in Brain Function (Quantitative EEG Cordance) During Placebo Lead-In and Treatment Outcomes in Clinical Trials for Major Depression
Am J Psychiatry,
August 1, 2006;
163(8):
1426 - 1432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Vallance
Something out of nothing: the placebo effect
Adv. Psychiatr. Treat.,
July 1, 2006;
12(4):
287 - 296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kraemer
Something Happens: Elements of Therapeutic Change
Clinical Child Psychology and Psychiatry,
April 1, 2006;
11(2):
239 - 248.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. J. MITCHELL
Two-week delay in onset of action of antidepressants: new evidence
The British Journal of Psychiatry,
February 1, 2006;
188(2):
105 - 106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Benedetti, H. S. Mayberg, T. D. Wager, C. S. Stohler, and J.-K. Zubieta
Neurobiological Mechanisms of the Placebo Effect
J. Neurosci.,
November 9, 2005;
25(45):
10390 - 10402.
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. F. Bailer, G. K. Frank, S. E. Henry, J. C. Price, C. C. Meltzer, L. Weissfeld, C. A. Mathis, W. C. Drevets, A. Wagner, J. Hoge, et al.
Altered Brain Serotonin 5-HT1A Receptor Binding After Recovery From Anorexia Nervosa Measured by Positron Emission Tomography and [Carbonyl11C]WAY-100635
Arch Gen Psychiatry,
September 1, 2005;
62(9):
1032 - 1041.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F. Schatzberg
Recent Studies of the Biology and Treatment of Depression
Focus,
January 1, 2005;
3(1):
14 - 24.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Videbech and B. Ravnkilde
Hippocampal Volume and Depression: A Meta-Analysis of MRI Studies
Am J Psychiatry,
November 1, 2004;
161(11):
1957 - 1966.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Goldapple, Z. Segal, C. Garson, M. Lau, P. Bieling, S. Kennedy, and H. Mayberg
Modulation of Cortical-Limbic Pathways in Major Depression: Treatment-Specific Effects of Cognitive Behavior Therapy
Arch Gen Psychiatry,
January 1, 2004;
61(1):
34 - 41.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Beutel, E. Stern, and D. A. Silbersweig
The Emerging Dialogue Between Psychoanalysis and Neuroscience: Neuroimaging Perspectives
J Am Psychoanal Assoc,
September 1, 2003;
51(3):
773 - 801.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Benedetti, A. Pollo, L. Lopiano, M. Lanotte, S. Vighetti, and I. Rainero
Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses
J. Neurosci.,
May 15, 2003;
23(10):
4315 - 4323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. S Mayberg
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment
Br. Med. Bull.,
March 1, 2003;
65(1):
193 - 207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. MULLER
Brain Changes and Placebo
Am J Psychiatry,
February 1, 2003;
160(2):
389 - 390.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Benedetti
How the Doctor's Words Affect the Patient's Brain
Eval Health Prof,
December 1, 2002;
25(4):
369 - 386.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. de la Fuentefernandez and A. J. Stoessl
The Biochemical Bases for Reward: Implications for the Placebo Effect
Eval Health Prof,
December 1, 2002;
25(4):
387 - 398.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Liotti, H. S. Mayberg, S. McGinnis, S. L. Brannan, and P. Jerabek
Unmasking Disease-Specific Cerebral Blood Flow Abnormalities: Mood Challenge in Patients With Remitted Unipolar Depression
Am J Psychiatry,
November 1, 2002;
159(11):
1830 - 1840.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
